European equities offer access to global companies
Overuse of antibiotics around the globe has created a worrying increase in resistance to many commonly used drugs, writes Carl Harald Janson, lead manager on the International Biotechnology trust.
The implications of the surprise leave result in the EU referendum continues to reverberate around the markets. The leave campaign's assertion that there will be no economic disruption from a Brexit is being tested.
Falling commodities weaken sentiment
The UK healthcare sector is a major beneficiary of EU R&D funding, free-movement of scientists, and a regulatory framework that expedites product approvals across the continent, writes Quilter Cheviot's Amish Patel.
Inflation-linked bonds have been out of favour for the past three years as global developed market headline inflation rates and inflation expectations have fallen in the face of tepid economic demand and weak oil and commodity prices.
US oil producers' prospects appear to have been dented by the collapse in the oil price that began two years ago. Unlike many countries in the oil producing world, the US has not had a National Oil Company (NOC) to ensure production can be financed and...